Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.320 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.310 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.310 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic silencing of lncRNA MORT in 16 TCGA cancer types. | 29707199 | 2018 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. | 28690657 | 2017 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. | 28690657 | 2017 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. | 28690657 | 2017 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. | 28690657 | 2017 |
||||||||
|
|
0.300 | Biomarker | CTD_human | Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes. | 28690657 | 2017 |